GENE-28. CLINICAL AND MOLECULAR ANALYSES OF LONG-TERM SURVIVORS OF GLIOBLASTOMA

Glioblastoma (GBM) is a uniformly fatal disease with standard treatments conferring a median overall survival of only 14.6 months. Because of limited local control with these frontline therapies, less than 10% of patients will survive five years. The molecular mechanisms that promote improved therap...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neuro Oncol
Asıl Yazarlar: Burgenske, Danielle, Eckel-Passow, Jeanette, Decker, Paul, Kosel, Matthew, Youland, Ryan, Remonde, Dioval, Kollmeyer, Thomas, Sicotte, Hugues, Caron, Alissa, Giannini, Caterina, Lachance, Daniel, Jenkins, Robert, Sarkaria, Jann
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2017
Konular:
Abstracts
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5691876/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.402
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller